Philippi, W.Va. – Alderson Broaddus University is pleased to announce that Dr. Yi Charlie Chen, professor of biology, has been selected to join more than 350 cancer researchers from prominent research institutions in 31 countries in a project that hopes to tackle cancer’s complexity.The initiative is called “The Halifax Project” and involves two separate task forces.

One task force will take what has been learned about cancer’s complexity to design an entirely new approach to therapy, while the other will assess whether or not everyday exposures to mixtures of commonly encountered chemicals have a role to play in cancer causation.  

This collaborative international initiative is being led by a Non-Governmental Organization called “Getting to Know Cancer”, and within the project, Dr. Yi Charlie Chen will be working on one of 12 cross-functional teams of scientists that will each be focused on a different aspect of cancer biology.

"Dr. Chen is an exemplary faculty on the Alderson Broaddus University campus,” said Joan Propst, provost and executive vice president for academic affairs at Alderson Broaddus University. “He is an exceptional teacher and researcher. It would be my hope that Dr. Chen's involvement in this work would help in the ongoing study of cancer and in the quest for a cure. He is well prepared for this work and will make significant contributions to the body of knowledge surrounding cancer."

The teams will spend the next year reviewing what we now know about cancer’s complexity to design a ground-breaking “broad-spectrum” therapeutic approach that will be aimed at many prioritized targets simultaneously.

“For far too long, our mainstream model for treating cancer has been erroneously focused on mostly single intervention strategies,” said Keith I. Block, M.D., the Medical and Scientific Director of the Block Center for Integrative Cancer Treatment in Skokie, Illinois. “Because for the past several decades it was felt that if the Achilles heel of the disease could be discovered, and that a treatment could be found that would eradicate the one underlying defect responsible for promoting and driving malignant disease.  However, we have since learned that cancer is a far more complex disorder with not one, but multiple defects. To overcome these defects – and be genuinely successful – an innovative, multi-pronged and multi-targeted approach to treatment is essential.”

Block also commented on the global collaborative.

“While we have worked quietly over many years on growing this multi-dimensional treatment model, the ‘Halifax Project’ represents the first global initiative that involves the collaboration of a large number of the very best cancer scientists and researchers from around the world,” Block said. “Our team’s objective is to further evolve a comprehensive treatment model with less toxic and more innovative therapies, with the ultimate goal of eradicating cancer.”

About Getting to Know Cancer

Getting to Know Cancer Cooperative Ltd, is a public-interest, non-profit organization based in Nova Scotia, Canada that was launched in 2011 with a mission is to instigate applied integrative cancer research. The organization’s inception was inspired by a number of cancer-related deaths in the families of the two cofounders, and they have since been focused on finding ways to address a number of systemic barriers that they believe are slowing down the progress of cancer research.  For more information, please visit the organization’s website

Contact Information:  

Leroy Lowe, President and Cofounder
Getting to Know Cancer
36 Arthur Street, Truro, Nova Scotia, Canada   B2N 1X5
Tel: (902) 893-5362 / Cell: 902-890-3070